Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients
Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients: a Randomized Phase III Trial, CIRRO (The Lundbeck Foundation Center for International Research in Radiation Oncology)
Sponsor: Danish Breast Cancer Cooperative Group
Listed as NCT00909818, this NA trial focuses on Breast Cancer and Carcinoma in Situ of the Breast and remains ongoing. Sponsored by Danish Breast Cancer Cooperative Group, it has been updated 11 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Sep 2021 — Jun 2024 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE2 → NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
May 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Breast Cancer Cooperative Group
- Danish Cancer Society
For direct contact, visit the study record on ClinicalTrials.gov .